MD Sharvil Patel says company plans to begin phase-3 in December, upon approval, and expects to have final data by March-April 2021. The company plans to test the ZyCoV-D vaccine on about 15,000-20,000 people in Phase-3 and is hopeful of launching it in the first half of 2021.Covid Vaccine: Zydus Cadila completes phase-2 trial, to submit data in November
MD Sharvil Patel says company plans to begin phase-3 in December, upon approval, and expects to have final data by March-April 2021. The company plans to test the ZyCoV-D vaccine on about 15,000-20,000 people in Phase-3 and is hopeful of launching it in the first half of 2021.
Subscribe to:
Post Comments (Atom)
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
-
The NCLT#39;s Ahmedabad bench has directed the RP to include GAIL in the list of creditors for both the companies.
-
"The (latest) investment will be used to grow the mobile esports format and establish presence in select overseas markets through its ...
No comments:
Post a Comment